TCG Crossover Management, LLC Diversified Active

Location: Palo Alto, CA

CIK: 0001839948 · Show all filings

Period: Q2 2024 (← Previous) (Next →)

Filing Date: Aug 14, 2024

Total Value: $960M (100.0% shares, 0.0% debt)

Holdings (32)

CGON CG ONCOLOGY, INC. 12.1%

Value $116M Shares 3,670,206 Est. Cost $40.67 Unrealized -14.8%

DYN DYNE THERAPEUTICS, INC 9.7%

Value $93.52M Shares 2,650,150 Est. Cost $16.62 Unrealized +74.8%

ABVX Abivax SA 8.3%

Value $80.07M Shares 6,056,596 Est. Cost $12.76 Unrealized —

SLN SILENCE THERAPEUTICS PLC 6.5%

Value $62.61M Shares 3,295,350 Est. Cost $14.21 Unrealized —

COGT COGENT BIOSCIENCES INC 6.1%

Value $58.71M Shares 6,964,375 Est. Cost $9.05 Unrealized -16.2%

SVRA SAVARA INC. 5.2%

Value $49.82M Shares 12,362,205 Est. Cost $3.73 Unrealized +19.2%

MDGL MADRIGAL PHARMACEUTICALS INC 4.4%

Value $41.82M Shares 149,283 Est. Cost $110.42 Unrealized +115.6%

EWTX EDGEWISE THERAPEUTICS, INC. 4.3%

Value $40.93M Shares 2,272,728 Est. Cost $15.89 Unrealized +9.7%

KROS KEROS THERAPEUTICS, INC. 4.2%

Value $40.19M Shares 879,344 Est. Cost $59.30 Unrealized -9.4%

MLYS MINERALYS THERAPEUTICS, INC. 3.9%

Value $37.27M Shares 3,185,185 Est. Cost $12.35 Unrealized +2.0%

OCUL OCULAR THERAPEUTIX, INC. 3.8%

Value $36.38M Shares 5,319,148 Est. Cost $7.10 Unrealized -13.0%

TYRA TYRA BIOSCIENCES INC 3.3%

Value $31.81M Shares 1,989,103 Est. Cost $12.71 Unrealized +35.5%

KURA KURA ONCOLOGY INC 3.1%

Value $29.31M Shares 1,423,642 Est. Cost $14.54 Unrealized +41.3%

GPCR STRUCTURE THERAPEUTICS INC 2.8%

Value $27.27M Shares 694,547 Est. Cost $43.22 Unrealized —

CNTA CENTESSA PHARMACEUTICALS PLC 2.7%

Value $26.1M Shares 2,890,816 Est. Cost $7.22 Unrealized —

— ASTRIA THERAPEUTICS, INC. 2.6%

Value $25.13M Shares 2,761,861 Est. Cost $14.07 Unrealized —

CMPS COMPASS PATHWAYS PLC 2.4%

Value $23.3M Shares 3,858,000 Est. Cost $7.40 Unrealized —

— SOLENO THERAPEUTIVS, INC. 2.3%

Value $22.44M Shares 550,000 Est. Cost $42.80 Unrealized —

IRON Disc Medicine, Inc. 2.3%

Value $21.95M Shares 486,957 Est. Cost $33.98 Unrealized 0.0%

— TOURMALINE BIO INC 2.0%

Value $19M Shares 1,477,593 Est. Cost $25.14 Unrealized —

TARS TARSUS PHARMACEUTICALS, INC. 1.6%

Value $15.12M Shares 556,317 Est. Cost $17.70 Unrealized +90.0%

— ADVERUM BIOTECHNOLOGIES, INC. 1.4%

Value $13.78M Shares 2,008,340 Est. Cost $14.14 Unrealized —

— VISTAGEN THERAPEUTICS INC 1.0%

Value $9.314M Shares 2,676,580 Est. Cost $5.14 Unrealized —

TRDA ENTRADA THERAPEUTICS INC 0.9%

Value $8.336M Shares 584,955 Est. Cost $17.12 Unrealized —

EYPT EyePoint Pharmaceuticals, Inc. 0.8%

Value $8.024M Shares 922,335 Est. Cost $13.97 Unrealized 0.0%

CCCC C4 THERAPEUTICS, INC. 0.6%

Value $5.898M Shares 1,276,574 Est. Cost $5.83 Unrealized +2.3%

— NEKTAR THERAPEUTICS 0.5%

Value $4.96M Shares 4,000,000 Est. Cost $0.93 Unrealized —

— AEROVATE THERAPEUTICS INC 0.4%

Value $3.72M Shares 2,240,809 Est. Cost $15.50 Unrealized —

ANTX AN2 Therapeutics, Inc. 0.3%

Value $3.344M Shares 1,555,118 Est. Cost $9.33 Unrealized -74.5%

KOD KODIAK SCIENCES INC 0.2%

Value $2.115M Shares 899,999 Est. Cost $4.10 Unrealized -17.4%

VTYX VENTYX BIOSCIENCES, INC 0.1%

Value $730K Shares 316,195 Est. Cost $29.94 Unrealized -86.1%

CABA CABALETTA BIO, INC 0.1%

Value $649K Shares 86,795 Est. Cost $3.64 Unrealized +236.6%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
CGON	CG ONCOLOGY, INC.	3,670,206	$116M	12.1%	$40.67	-14.8%	COMM	156944100
DYN	DYNE THERAPEUTICS, INC	2,650,150	$93.52M	9.7%	$16.62	+74.8%	COMM	26818M108
ABVX	Abivax SA	6,056,596	$80.07M	8.3%	$12.76	—	ADRS	00370M103
SLN	SILENCE THERAPEUTICS PLC	3,295,350	$62.61M	6.5%	$14.21	—	ADRS	82686Q101
COGT	COGENT BIOSCIENCES INC	6,964,375	$58.71M	6.1%	$9.05	-16.2%	COMM	19240Q201
SVRA	SAVARA INC.	12,362,205	$49.82M	5.2%	$3.73	+19.2%	COMM	805111101
MDGL	MADRIGAL PHARMACEUTICALS INC	149,283	$41.82M	4.4%	$110.42	+115.6%	COMM	558868105
EWTX	EDGEWISE THERAPEUTICS, INC.	2,272,728	$40.93M	4.3%	$15.89	+9.7%	COMM	28036F105
KROS	KEROS THERAPEUTICS, INC.	879,344	$40.19M	4.2%	$59.30	-9.4%	COMM	492327101
MLYS	MINERALYS THERAPEUTICS, INC.	3,185,185	$37.27M	3.9%	$12.35	+2.0%	COMM	603170101
OCUL	OCULAR THERAPEUTIX, INC.	5,319,148	$36.38M	3.8%	$7.10	-13.0%	COMM	67576A100
TYRA	TYRA BIOSCIENCES INC	1,989,103	$31.81M	3.3%	$12.71	+35.5%	COMM	90240B106
KURA	KURA ONCOLOGY INC	1,423,642	$29.31M	3.1%	$14.54	+41.3%	COMM	50127T109
GPCR	STRUCTURE THERAPEUTICS INC	694,547	$27.27M	2.8%	$43.22	—	ADRS	86366E106
CNTA	CENTESSA PHARMACEUTICALS PLC	2,890,816	$26.1M	2.7%	$7.22	—	COMM	152309100
—	ASTRIA THERAPEUTICS, INC.	2,761,861	$25.13M	2.6%	$14.07	—	COMM	04635X102
CMPS	COMPASS PATHWAYS PLC	3,858,000	$23.3M	2.4%	$7.40	—	ADRS	20451W101
—	SOLENO THERAPEUTIVS, INC.	550,000	$22.44M	2.3%	$42.80	—	COMM	834203200
IRON	Disc Medicine, Inc.	486,957	$21.95M	2.3%	$33.98	0.0%	COMM	254604101
—	TOURMALINE BIO INC	1,477,593	$19M	2.0%	$25.14	—	COMM	89157D105
TARS	TARSUS PHARMACEUTICALS, INC.	556,317	$15.12M	1.6%	$17.70	+90.0%	COMM	87650L103
—	ADVERUM BIOTECHNOLOGIES, INC.	2,008,340	$13.78M	1.4%	$14.14	—	COMM	00773U108
—	VISTAGEN THERAPEUTICS INC	2,676,580	$9.314M	1.0%	$5.14	—	COMM	92840H202
TRDA	ENTRADA THERAPEUTICS INC	584,955	$8.336M	0.9%	$17.12	—	COMM	29384C108
EYPT	EyePoint Pharmaceuticals, Inc.	922,335	$8.024M	0.8%	$13.97	0.0%	COMM	30233G209
CCCC	C4 THERAPEUTICS, INC.	1,276,574	$5.898M	0.6%	$5.83	+2.3%	COMM	12529R107
—	NEKTAR THERAPEUTICS	4,000,000	$4.96M	0.5%	$0.93	—	COMM	640268108
—	AEROVATE THERAPEUTICS INC	2,240,809	$3.72M	0.4%	$15.50	—	COMM	008064107
ANTX	AN2 Therapeutics, Inc.	1,555,118	$3.344M	0.3%	$9.33	-74.5%	COMM	037326105
KOD	KODIAK SCIENCES INC	899,999	$2.115M	0.2%	$4.10	-17.4%	COMM	50015M109
VTYX	VENTYX BIOSCIENCES, INC	316,195	$730K	0.1%	$29.94	-86.1%	COMM	92332V107
CABA	CABALETTA BIO, INC	86,795	$649K	0.1%	$3.64	+236.6%	COMM	12674W109